Bfsg, LLC Roivant Sciences Ltd. Transaction History
Bfsg, LLC
- $774 Million
- Q2 2024
A detailed history of Bfsg, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Bfsg, LLC holds 1,500 shares of ROIV stock, worth $17,310. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 500
200.0%
Holding current value
$17,310
Previous $5,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$824 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$798 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$770 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$408 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$338 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.13B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...